May 10, 2017
News, research & analysis from the global Biopharmaceutical and related industries.
April 21, 2017
April 12, 2017
[vc_row][vc_column][vc_column_text]GE Healthcare recently announced the acquisition of British cryogenic processing company Asymptote for an undisclosed price, strengthening its cell therapy portfolio with technologies designed to enable […]
April 4, 2017
[vc_row][vc_column][vc_column_text] California-based Immunodiagnostics company Singulex have announced that they have received CE marking for the Sgx Clarity® system, a fully-automated IVD platform powered by the company’s […]
March 2, 2017
[vc_row][vc_column][vc_column_text] In September 2016 the International Working Group for Antibody Validation (IWGAV) finally announced their five conceptual pillars, outlining recommendations to mitigate the antibody specificity and […]
February 20, 2017
[vc_row][vc_column][vc_column_text] Fully integrated contract research and manufacturing organisation Pharmaron have formally opened their Hoddesdon facility, making it the first Sino-US CRO to operate in each major […]
January 31, 2017
[vc_row][vc_column][vc_column_text] Healthcare multinational Johnson & Johnson will pay $30B to acquire Swiss drugmaker Actelion in an all-cash deal. Under the conditions of the deal, Actelion will […]
January 27, 2017
[vc_row][vc_column][vc_column_text] At the end of 2016 Lonza entered into an agreement to acquire Capsugel for $5.5B in cash, including refinancing of $2B of existing Capsugel debt. […]
January 12, 2017
[vc_row][vc_column][vc_column_text] Whilst the depression in the value and frequency of Drug Development IPOs on the NASDAQ market continued throughout the fourth quarter of 2016, a combined […]